The GI Hepatology department seeks adults over 18 who are inpatients with Hepatorenal syndrome (HRS), a type of kidney failure that progresses rapidly and is caused by liver failure, for a research study. The purpose of the study is to see if an investigational drug is a safe and effective treatment for HRS.
Study involves up to 14 days of IV treatment while you are an inpatient, 1 follow up visit, and two follow up phone calls. Total study participation is approximately 3 months.
Study-related medication is provided free of charge.
$100 for completing the follow up visit